Articles by Erin Slifka

Light Helmets circumvents locker-room gatekeepers and makes endorsement deals in a bid for visibility.

Plus, Tesla is gaining ground in the U.S., and what it’s like to retire to a low-tax state.

The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.

U.S. EV sales remain depressed, but Tesla’s market share has recovered from its 2025 nadir.

A star dealmaker’s defection reveals two starkly different views of the legal world’s race for scale.

The health-products company said it planned to hive off its DePuy Synthes unit to focus on higher-growth areas.

The billionaire said that no stock was sold, and that he canceled a plan to unload 50 million shares.